Ignite Creation Date:
2024-05-06 @ 8:07 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06263153
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2024-02-08
Brief Title:
Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy
Sponsor:
Yuanquan Yang
Organization:
Ohio State University Comprehensive Cancer Center
Organization Data
Organization:
Ohio State University Comprehensive Cancer Center
Class:
OTHER
Study ID:
OSU-23329
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Yuanquan Yang
Lead Sponsor Class:
OTHER
Responsible Party:
Yuanquan Yang
Responsible Party Title:
Principal Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Ohio State University Comprehensive Cancer Center
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Gateway for Cancer Research | OTHER |